Impact of systemic Immune–inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer

Author:

Rajwa Pawel,Schuettfort Victor M,D'Andrea David,Quhal Fahad,Mori Keiichiro,Katayama Satoshi,Laukhtina Ekaterina,Pradere Benjamin,Motlagh Reza Sari,Mostafaei Hadi,Grossmann Nico C,Huebner Nicolai,Aulitzky Andreas,Mun Dong-Ho,Briganti Alberto,Karakiewicz Pierre I,Fajkovic Harun,Shariat Shahrokh F

Funder

Department of Local Government, Sport and Cultural Industries Office of Multicultural Interests

Open Society Foundations

European Association of Urology

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference32 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent;Mottet;Eur Urol,2020

3. Considering the role of radical prostatectomy in 21st century prostate cancer care;Costello;Nat Rev Urol,2020

4. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review;Van den Broeck;Eur Urol,2019

5. Tumor markers in prostate cancer I: blood-based markers;Shariat;Acta Oncol,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3